Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models

Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use

(2011) KYOUNG-YOON KIM et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Neural Stem Cell-based Gene Therapy for Brain Tumors

(2010) Seung U. Kim   Stem Cell Reviews and Reports

Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth

(2009) Ki-Yon Kim et al.   CANCER SCIENCE

Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model

(2009) Mi-Hyeon You et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Prodrug cancer gene therapy

(2008) Cestmir Altaner   CANCER LETTERS

Stem and progenitor cell-mediated tumor selective gene therapy

(2008) K S Aboody et al.   GENE THERAPY

Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model

(2008) C Ren et al.   GENE THERAPY

Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia

(2008) D. Zhao et al.   MOLECULAR CANCER RESEARCH

Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas

(2008) Jörg Dietrich et al.   Nature clinical practice. Oncology